Over-the Counter Drug Litigation
by wendy on 10/12/07 at 7:38 pm
Zicam Products, Fleet Enemas, and More
Recording Date: December 9, 2009
Duration: 103 minutes
Didn’t Attend?
Purchase the
Teleconference
Audio Package $149
Purchase the Teleconference Audio Package (includes MP3 files and handbook on CD). To order or learn more, click here or contact Allison Emery at 484-324-2755 x205 or allison.emery@litigationconferences.com.
Attendees get the teleconference Audio Package for 50% off!
Agenda and Speakers
Zicam Products, Fleet Enemas, and More
- Strategies for client screening and ensuring your case has evidentiary support
- Understanding the differences between prescribed and over the counter (OTC) drug litigations
- The FDA’s role in regulating over the counter drugs-is it effective, what can be improved and how to achieve this
- Recent OTC litigations:
- Important Considerations for Evaluating Zicam Cases
- What drugs are covered by the FDA’s recent recall and their market penetration
- Long term and short term side effects of the suspect Zicam products – Anosmia, loss of taste, depression, malnutrition, and others
- How to screen your clients in a Zicam case
- What kind of evidence will you need?
- The kind of medical experts and reports you will need for your case
- The score board: what kind of settlements have been reached, the status of class actions, and the financial prospects of Matrixx in light of the recall
- Making the decision to settle or try your Zicam case
- The FDA’s role in reviewing homeopathic drugs like Matrixx’ Zicam
- Fleet
- Enemas – what brands are causing injury? What about generics?
- Long term and short term injuries to the kidneys
- Course of treatment and likely success
- The number of lawsuits, where they are being filed and the potential damages
- How to value a claim
- Important Considerations for Evaluating Zicam Cases
Faculty:
Hirlye R. “Ryan” Lutz, III, Esq., Cory Watson Crowder & DeGaris, Birmingham
Stacy Hauer, Esq., Zimmerman Reed, Minneapolis

